Articles & Essays

Newspaper Articles and Commentary

  • What Does ‘Bona Fide Competition’ Actually Mean in the Biologics Market?STAT ()
  • Rebooting America: Innovation Policy, 40 Duke Law Magazine ()
  • Acknowledging the Public Role in Private Drug Development: Lessons From RemdesivirSTAT () (with Justin Hughes)
  • Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry?, 323 JAMA ( 821-822) (with Lawrence O. Gostin)
  • The Need for Speed: Process and Product Quality in Track 1, Law 360 () (with Elliot Chen)
  • Letter to U.S. Senate Committee on the Judiciary Concerning Inter Partes Review and Orange Book-Listed Patents, Letter to the U.S. Senate Committee on the Judiciary ()
  • Use Patents Can Be Useful: The Case of Rescued Drugs () (with Grant Rice)
  • Taming the Mongrel: Aligning Appellate Review of Claim Construction with its Evidentiary Character in Teva v. Sandoz, Patentlyo () (with others)
  • Patentable Subject Matter at the Supreme Court: An Exceptional Case?, SCOTUSblog ()
  • Moving Beyond "Isolated" Gene Patents, 341 Science () (with Robert Cook-Deegan)
Arti K. Rai portrait